StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
250
This year
35
Publishing Date
2024 - 03 - 27
2
2024 - 03 - 13
3
2024 - 03 - 05
2
2024 - 02 - 14
2
2024 - 01 - 26
2
2024 - 01 - 24
2
2024 - 01 - 17
3
2023 - 12 - 14
2
2023 - 06 - 30
2
2023 - 06 - 29
2
2023 - 06 - 23
2
2023 - 06 - 08
2
2023 - 05 - 17
2
2023 - 05 - 12
2
2023 - 04 - 26
2
2023 - 03 - 28
2
2023 - 02 - 24
3
2023 - 02 - 20
2
2023 - 02 - 17
2
2023 - 02 - 16
3
2023 - 02 - 15
2
2023 - 02 - 13
2
2023 - 01 - 26
2
2023 - 01 - 16
3
2023 - 01 - 03
2
2022 - 12 - 30
2
2022 - 11 - 03
2
2022 - 09 - 16
2
2022 - 09 - 09
2
2022 - 08 - 03
2
2022 - 08 - 02
3
2022 - 06 - 17
2
2022 - 06 - 13
2
2022 - 05 - 27
2
2022 - 05 - 05
2
2022 - 04 - 07
2
2022 - 03 - 25
2
2022 - 03 - 23
2
2022 - 03 - 22
2
2022 - 03 - 01
1
2022 - 02 - 25
2
2022 - 02 - 22
1
2022 - 02 - 17
1
2022 - 01 - 21
1
2022 - 01 - 19
1
2022 - 01 - 18
1
2022 - 01 - 13
1
2021 - 12 - 31
1
2021 - 12 - 24
1
2021 - 12 - 06
1
2021 - 11 - 12
1
2021 - 11 - 11
1
2021 - 11 - 02
2
2021 - 10 - 29
1
2021 - 10 - 28
2
2021 - 10 - 22
1
2021 - 10 - 18
1
2021 - 10 - 13
1
2021 - 10 - 08
1
2021 - 10 - 01
1
Sector
Commercial services
2
Consumer non-durables
5
Consumer services
1
Distribution services
2
Electronic technology
3
Finance
1
Health services
7
Health technology
250
Information
1
Manufacturing
25
Mining, quarrying, and oil and gas extraction
1
N/a
16
Process industries
4
Producer manufacturing
6
Professional, scientific, and technical services
6
Retail trade
1
Technology services
4
Tags
Active
2
Advanced
2
Alzheimer's
2
America
8
Antibody
2
Application
3
Biosimilar
6
Business
8
Cancer
29
Companies
3
Covid-19
3
Diabetes
4
Diagnostic
3
Diagnostics
6
Disease
12
Distribution
3
Drug
36
Earnings
17
Expansion
4
Expected
5
Eye
3
Fibrosis
3
Financial
20
Financial results
4
Global
129
Growing
9
Growth
51
Health
5
Immunotherapy
5
Impact
4
Key
3
Lung
3
Market
184
Merck
3
Molecular
3
N/a
228
Novartis
9
Patent
3
Pharma
5
Pharmaceuticals
5
Pipeline
3
Rare
3
Reach
7
Report
194
Research
50
Respiratory
6
Results
30
Roche
3
Sanofi
4
Skin
3
Smart
5
Technology
3
Test
3
Teva
4
Therapeutics
20
Therapy
17
Transdermal
3
Treatment
23
Update
8
Year
9
Entities
3m company
5
Abbott laboratories
32
Abbvie inc.
47
Adaptimmune therapeutics plc
3
Agilent technologies, inc.
3
Alkermes plc
5
Alvotech lux holdings s.a.s.
2
Amgen inc.
29
Applied genetic technologies corporation
2
Aptargroup, inc.
3
Astellas pharma inc
13
Astrazeneca plc
49
Autolus therapeutics plc
2
Bausch health companies inc.
9
Baxter international inc.
7
Becton, dickinson and company
6
Beigene, ltd.
3
Bio-rad laboratories, inc.
4
Biogen inc.
7
Biontech se
4
Boston scientific corporation
3
Bristol-myers squibb company
34
Csl ltd
3
Danaher corporation
6
Eli lilly and company
48
Endo international plc
4
Genmab a/s
4
Gilead sciences, inc.
12
Glaxosmithkline plc
66
Hologic, inc.
3
Illumina, inc.
4
Incyte corporation
8
Ionis pharmaceuticals, inc.
3
Jazz pharmaceuticals plc
4
Johnson & johnson
74
Koninklijke philips n.v.
8
Mallinckrodt plc
4
Medtronic plc
11
Morphosys ag
6
Novartis ag
250
Novo nordisk a/s
11
Perrigo company
3
Pfizer, inc.
19
Precision biosciences, inc.
6
Qiagen n.v.
3
Reckitt benckiser group plc
3
Regeneron pharmaceuticals, inc.
4
Regenxbio inc.
7
Sanofi
72
Sarepta therapeutics, inc.
3
Stryker corporation
3
Takeda pharmaceutical company limited
22
Terumo corp
3
Teva pharmaceutical industries ltd
46
Thermo fisher scientific inc
14
Ucb s.a.
3
Ultragenyx pharmaceutical inc.
4
Uniqure n.v.
4
Viatris inc.
17
Xencor, inc.
6
Symbols
A
121
AAPL
189
ABB
308
ABBV
159
ABLZF
253
ABT
413
ACM
124
ACN
111
ARVL
281
ASML
119
AZN
139
AZNCF
122
BDX
242
BIO
168
BMY
118
CSCO
160
DD
133
DHR
240
DNZOF
118
DNZOY
118
DOW
154
ERIC
359
FNCTF
571
GE
235
GLAXF
164
GOOG
156
GOOGL
156
GSK
198
HON
434
IBM
120
IFNNF
117
IFNNY
113
INTC
216
JNJ
581
LLY
247
LMT
191
MDT
247
MMM
253
MS
137
MSFT
321
NIPNF
146
NOC
147
NVS
286
NVSEF
250
ORCL
243
PAYD
143
PCRFF
164
PCRFY
164
PHG
208
PPRUF
135
PPRUY
136
QGEN
115
RTX
113
SAP
254
SAPGF
214
SNY
575
SNYNF
475
TEVJF
124
TMO
429
XOM
122
Exchanges
Amex
1
Nasdaq
250
Nyse
250
Crawled Date
2024 - 03 - 27
2
2024 - 03 - 13
3
2024 - 03 - 05
2
2024 - 02 - 14
2
2024 - 01 - 26
2
2024 - 01 - 24
2
2024 - 01 - 17
3
2023 - 06 - 30
2
2023 - 06 - 29
2
2023 - 06 - 23
2
2023 - 06 - 08
2
2023 - 04 - 28
2
2023 - 04 - 26
2
2023 - 03 - 28
2
2023 - 02 - 24
3
2023 - 02 - 21
2
2023 - 02 - 17
2
2023 - 02 - 16
3
2023 - 02 - 15
2
2023 - 02 - 14
2
2023 - 01 - 27
2
2023 - 01 - 16
3
2023 - 01 - 03
2
2022 - 12 - 30
2
2022 - 11 - 03
2
2022 - 09 - 16
2
2022 - 09 - 09
2
2022 - 08 - 03
2
2022 - 08 - 02
3
2022 - 06 - 17
2
2022 - 06 - 13
2
2022 - 05 - 27
2
2022 - 05 - 05
2
2022 - 04 - 07
2
2022 - 03 - 25
2
2022 - 03 - 23
2
2022 - 03 - 22
2
2022 - 03 - 14
1
2022 - 03 - 08
1
2022 - 03 - 01
1
2022 - 02 - 25
2
2022 - 02 - 22
1
2022 - 02 - 17
1
2022 - 01 - 21
1
2022 - 01 - 19
1
2022 - 01 - 18
1
2022 - 01 - 13
1
2021 - 12 - 31
1
2021 - 12 - 24
1
2021 - 12 - 06
1
2021 - 11 - 12
1
2021 - 11 - 11
1
2021 - 11 - 02
2
2021 - 10 - 29
1
2021 - 10 - 28
2
2021 - 10 - 22
1
2021 - 10 - 18
1
2021 - 10 - 13
1
2021 - 10 - 08
1
2021 - 10 - 01
1
Crawled Time
00:00
13
00:20
2
01:00
9
02:00
6
03:00
9
04:00
1
04:20
3
05:00
4
07:00
3
08:00
1
09:00
5
10:00
5
11:00
12
11:01
1
12:00
22
12:20
6
12:30
2
13:00
3
13:20
5
14:00
11
14:20
5
15:00
9
15:20
5
15:30
4
16:00
11
16:20
2
17:00
20
18:00
18
19:00
11
20:00
14
21:00
8
22:00
10
23:00
10
Source
ir.voyagertherapeutics.com
1
www.biospace.com
22
www.globenewswire.com
6
www.precisionbiosciences.com
3
www.prnewswire.com
217
www.voyagertherapeutics.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
report
symbols :
Nvsef
save search
Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates and Financial Results
Published:
2024-03-27
(Crawled : 20:00)
- globenewswire.com
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.13%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
ERAS
|
$1.84
-4.66%
-4.61%
580K
|
|
-6.31%
|
O:
17.48%
H:
6.94%
C:
-14.88%
NVS
|
News
|
$93.08
-0.13%
0.13%
1.1M
|
Health Technology
|
-2.92%
|
O:
0.52%
H:
0.0%
C:
0.0%
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
-3.52%
|
O:
0.28%
H:
1.71%
C:
-0.3%
business
year
financial
results
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update
Published:
2024-03-27
(Crawled : 11:00)
- biospace.com/
CRBU
|
$3.91
-2.49%
-2.3%
1.7M
|
Health Technology
|
-20.75%
|
O:
1.58%
H:
0.58%
C:
-0.39%
NVS
|
News
|
$93.08
-0.13%
0.13%
1.1M
|
Health Technology
|
-2.3%
|
O:
0.24%
H:
0.42%
C:
0.4%
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
-3.11%
|
O:
0.49%
H:
0.84%
C:
-0.07%
TGTX
|
$13.82
-1.29%
-1.27%
2.7M
|
Health Technology
|
-10.49%
|
O:
0.71%
H:
0.39%
C:
0.13%
DTIL
|
$11.51
-10.57%
-11.91%
220K
|
Health Technology
|
0.94%
|
O:
0.39%
H:
4.22%
C:
1.41%
precision
business
year
update
financial
results
Global OTC Artificial Tears Analysis Report 2023-2030: The Influence of Smart Technologies, Market Positioned for Continued Expansion Amid Growing Focus on Eye Wellness
Published:
2024-03-21
(Crawled : 00:00)
- prnewswire.com
NVS
|
News
|
$93.08
-0.13%
0.13%
1.1M
|
Health Technology
|
-3.12%
|
O:
0.17%
H:
0.28%
C:
-0.01%
JNJ
|
News
|
$144.77
0.22%
0.22%
7.9M
|
Health Technology
|
-6.92%
|
O:
0.02%
H:
0.0%
C:
0.0%
BHC
|
$8.66
-0.92%
-0.58%
2.2M
|
Health Technology
|
-8.0%
|
O:
-0.74%
H:
1.54%
C:
1.38%
ABBV
|
$164.25
1.05%
0.26%
3M
|
Health Technology
|
-7.19%
|
O:
0.16%
H:
0.0%
C:
0.0%
report
expansion
global
wellness
smart
growing
eye
market
MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published:
2024-03-13
(Crawled : 23:00)
- biospace.com/
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-4.76%
|
O:
-0.23%
H:
0.0%
C:
0.0%
NVS
|
News
|
$93.08
-0.13%
0.13%
1.1M
|
Health Technology
|
-6.71%
|
O:
-0.07%
H:
0.09%
C:
-0.7%
XNCR
|
$19.07
0.79%
0.84%
460K
|
Health Technology
|
-16.36%
|
O:
-0.66%
H:
4.19%
C:
3.13%
MOR
|
News
|
$18.04
0.5%
0.44%
400K
|
Health Technology
|
-0.72%
|
O:
0.22%
H:
0.22%
C:
-0.93%
INCY
|
$52.72
-0.94%
-0.91%
2.1M
|
Health Technology
|
-11.14%
|
O:
0.03%
H:
1.47%
C:
-0.72%
year
update
financial
results
Global Irritable Bowel Disease (IBD) Market Research Report 2024: Corticosteroids, JAK inhibitors, TNF inhibitors, Other Drug Classes Insights and Forecast 2019-2029
Published:
2024-03-13
(Crawled : 03:00)
- prnewswire.com
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-4.76%
|
O:
-0.23%
H:
0.0%
C:
0.0%
NVS
|
News
|
$93.08
-0.13%
0.13%
1.1M
|
Health Technology
|
-6.71%
|
O:
-0.07%
H:
0.09%
C:
-0.7%
JNJ
|
News
|
$144.77
0.22%
0.22%
7.9M
|
Health Technology
|
-10.31%
|
O:
0.66%
H:
0.0%
C:
0.0%
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
-0.55%
|
O:
0.27%
H:
0.5%
C:
0.11%
ABBV
|
$164.25
1.05%
0.26%
3M
|
Health Technology
|
-9.65%
|
O:
0.59%
H:
0.01%
C:
-1.45%
drug
disease
report
research
global
market
Global IgG Mediated Autoimmune Diseases Biologic Drugs Research Report 2023-2029: Shift Towards Personalized Medicine and Targeted Therapies & Adoption of Biosimilars and Biobetters
Published:
2024-03-13
(Crawled : 01:00)
- prnewswire.com
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-4.76%
|
O:
-0.23%
H:
0.0%
C:
0.0%
NVS
|
News
|
$93.08
-0.13%
0.13%
1.1M
|
Health Technology
|
-6.71%
|
O:
-0.07%
H:
0.09%
C:
-0.7%
JNJ
|
News
|
$144.77
0.22%
0.22%
7.9M
|
Health Technology
|
-10.31%
|
O:
0.66%
H:
0.0%
C:
0.0%
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
-0.55%
|
O:
0.27%
H:
0.5%
C:
0.11%
ABBV
|
$164.25
1.05%
0.26%
3M
|
Health Technology
|
-9.65%
|
O:
0.59%
H:
0.01%
C:
-1.45%
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
-4.61%
|
O:
-0.04%
H:
0.0%
C:
0.0%
report
research
global
Global Dilated Cardiomyopathy (DCM) Market Report 2024, with Company Profiles of the Top 10 Major Market Players
Published:
2024-03-07
(Crawled : 00:00)
- prnewswire.com
AZNCF
|
$140.15
3.58%
-4.19%
560
|
Health Technology
|
4.68%
|
O:
3.21%
H:
0.0%
C:
-1.71%
NVS
|
News
|
$93.08
-0.13%
0.13%
1.1M
|
Health Technology
|
-6.85%
|
O:
0.08%
H:
0.86%
C:
0.7%
JNJ
|
News
|
$144.77
0.22%
0.22%
7.9M
|
Health Technology
|
-9.54%
|
O:
-0.68%
H:
0.0%
C:
0.0%
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
-3.77%
|
O:
-0.02%
H:
0.0%
C:
-2.29%
ABT
|
News
|
$105.9
-3.03%
0.38%
11M
|
Health Technology
|
-10.13%
|
O:
0.58%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
-4.14%
|
O:
-0.08%
H:
0.0%
C:
0.0%
AZN
|
$68.53
0.39%
0.39%
3.2M
|
Health Technology
|
3.13%
|
O:
-0.03%
H:
0.62%
C:
0.5%
AMGN
|
$264.07
-0.59%
-0.59%
1.6M
|
Health Technology
|
-2.17%
|
O:
-0.02%
H:
1.37%
C:
0.34%
company
report
global
market
Global Respiratory Syncytial Virus Diagnostics Market Report 2024-2029: Rising Healthcare Expenditure, Technological Innovations, and Increased Incidence of RSV Fueling Growth
Published:
2024-03-05
(Crawled : 05:00)
- prnewswire.com
TMO
|
News
|
$547.25
-1.32%
-1.51%
1.2M
|
Health Technology
|
-5.91%
|
O:
-0.09%
H:
0.86%
C:
0.6%
DGX
|
$126.98
-0.35%
0.0%
890K
|
Health Services
|
1.68%
|
O:
0.38%
H:
0.69%
C:
-1.01%
NVS
|
News
|
$93.08
-0.13%
0.13%
1.1M
|
Health Technology
|
-8.72%
|
O:
0.32%
H:
0.22%
C:
-0.2%
BIO
|
$290.86
-0.65%
-1.0%
140K
|
Health Technology
|
-12.53%
|
O:
-0.53%
H:
1.08%
C:
-0.59%
ABT
|
News
|
$105.9
-3.03%
0.38%
11M
|
Health Technology
|
-8.93%
|
O:
1.6%
H:
0.0%
C:
0.0%
QDEL
|
News
M
|
$38.71
-3.95%
-4.19%
580K
|
Health Technology
|
-12.68%
|
O:
0.18%
H:
1.13%
C:
-3.31%
report
respiratory
global
rsv
virus
diagnostics
growth
market
Janus Kinase (JAK) Inhibitors Global Market Report 2024, Featuring Key Players Pfizer, Merck, AbbVie, Novartis, Sanofi, Bristol Myers Squibb, GSK, Takeda, Eli Lilly and Gilead Sciences
Published:
2024-03-05
(Crawled : 01:00)
- prnewswire.com
NVS
|
News
|
$93.08
-0.13%
0.13%
1.1M
|
Health Technology
|
-8.72%
|
O:
0.32%
H:
0.22%
C:
-0.2%
ABBV
|
$164.25
1.05%
0.26%
3M
|
Health Technology
|
-8.25%
|
O:
-0.24%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
-1.89%
|
O:
1.17%
H:
0.0%
C:
0.0%
report
sciences
global
key
market
Global Antibiotic Drugs Market Report 2024-2029: A $50.41 Billion Industry in 2022 - Focus on United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India
Published:
2024-02-28
(Crawled : 03:00)
- prnewswire.com
VTRS
|
$11.1
-0.18%
-0.23%
4.7M
|
Health Technology
|
-16.1%
|
O:
-0.15%
H:
2.57%
C:
-6.96%
NVS
|
News
|
$93.08
-0.13%
0.13%
1.1M
|
Health Technology
|
-9.76%
|
O:
0.05%
H:
0.06%
C:
-0.95%
JNJ
|
News
|
$144.77
0.22%
0.22%
7.9M
|
Health Technology
|
-9.52%
|
O:
0.67%
H:
0.0%
C:
0.0%
ABT
|
News
|
$105.9
-3.03%
0.38%
11M
|
Health Technology
|
-8.67%
|
O:
1.12%
H:
0.52%
C:
0.47%
report
india
global
market
REGENXBIO Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights
Published:
2024-02-27
(Crawled : 21:00)
- prnewswire.com
NVS
|
News
|
$93.08
-0.13%
0.13%
1.1M
|
Health Technology
|
-9.76%
|
O:
0.05%
H:
0.06%
C:
-0.95%
RGNX
|
News
|
$17.03
-2.69%
-2.88%
410K
|
Health Technology
|
-14.94%
|
O:
-5.04%
H:
5.42%
C:
4.68%
year
financial
results
Insulin Pen Global Market Outlook Report 2024-2028: Current Market Size and Revenue Growth Prospects for Insulin Pens, with Market Share Analysis by Type, Onset Time, End User and Geographical Region
Published:
2024-02-23
(Crawled : 17:00)
- prnewswire.com
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-8.97%
|
O:
0.37%
H:
0.58%
C:
0.58%
VTRS
|
$11.1
-0.18%
-0.23%
4.7M
|
Health Technology
|
-16.92%
|
O:
0.0%
H:
1.93%
C:
1.27%
NVO
|
News
|
$124.53
0.88%
0.19%
2.5M
|
Health Technology
|
0.01%
|
O:
-0.68%
H:
0.4%
C:
-0.18%
NVS
|
News
|
$93.08
-0.13%
0.13%
1.1M
|
Health Technology
|
-9.46%
|
O:
0.89%
H:
0.4%
C:
0.17%
JNJ
|
News
|
$144.77
0.22%
0.22%
7.9M
|
Health Technology
|
-9.77%
|
O:
0.28%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
-3.77%
|
O:
0.97%
H:
0.0%
C:
0.0%
report
revenue
global
insulin
growth
market
Global Incretin Based Drugs Research Report 2023: Market to Reach $64.28 Billion by 2029 from $40 Billion in 2022, Driven by Increasing Prevalence of Diabetes
Published:
2024-02-21
(Crawled : 02:00)
- prnewswire.com
AZNCF
|
$140.15
3.58%
-4.19%
560
|
Health Technology
|
5.3%
|
O:
-0.88%
H:
1.75%
C:
-0.29%
NVS
|
News
|
$93.08
-0.13%
0.13%
1.1M
|
Health Technology
|
-9.38%
|
O:
-0.65%
H:
0.62%
C:
0.5%
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
-0.65%
|
O:
-2.33%
H:
1.55%
C:
1.06%
AZN
|
$68.53
0.39%
0.39%
3.2M
|
Health Technology
|
4.96%
|
O:
-1.01%
H:
1.1%
C:
1.1%
report
reach
research
global
diabetes
market
Biosimilar Lymphocyte Modulator Global Market Report 2024 - Robust 10.6% CAGR Forecast, Amid Rising Autoimmune Disease Prevalence
Published:
2024-02-20
(Crawled : 03:00)
- prnewswire.com
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-6.46%
|
O:
2.81%
H:
0.0%
C:
-0.95%
NVS
|
News
|
$93.08
-0.13%
0.13%
1.1M
|
Health Technology
|
-7.1%
|
O:
2.91%
H:
0.35%
C:
-0.38%
BIIB
|
$192.16
-1.53%
-1.57%
1.1M
|
Health Technology
|
-10.92%
|
O:
-0.69%
H:
1.24%
C:
0.76%
disease
biosimilar
report
global
market
Global Intraocular Lens Market Report 2024: Market to Grow from $4.23 Billion in 2023 to $6.11 Billion by 2030 - Rising Incidence of Myopia and Diabetes Boosts Demand
Published:
2024-02-16
(Crawled : 23:00)
- prnewswire.com
BHC
|
$8.66
-0.92%
-0.58%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
ALC
|
$79.0
-0.77%
0.0%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
STAA
|
$46.34
-0.6%
-0.71%
230K
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$144.77
0.22%
0.22%
7.9M
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$93.08
-0.13%
0.13%
1.1M
|
Health Technology
|
Email alert
Add to watchlist
report
global
diabetes
market
Global Advanced Drug Delivery Systems Market Report 2024: Review of Patents and Patent Applications Filed on Drug Delivery Release Mechanisms and Novel Applications
Published:
2024-02-15
(Crawled : 23:00)
- prnewswire.com
TRUMF
|
$17.112
1.8%
-17.59%
1.5K
|
Health Technology
|
-53.57%
|
O:
0.79%
H:
0.0%
C:
-3.21%
SNYNF
|
News
|
$92.7
0.63%
-2.18%
1.4K
|
Health Technology
|
0.42%
|
O:
1.66%
H:
0.0%
C:
-1.59%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-5.89%
|
O:
1.66%
H:
0.0%
C:
-1.04%
TRUMY
|
$16.69
-1.77%
0.79%
53K
|
Manufacturing
|
-55.13%
|
O:
0.27%
H:
0.0%
C:
-2.6%
NVS
|
News
|
$93.08
-0.13%
0.13%
1.1M
|
Health Technology
|
-6.57%
|
O:
0.37%
H:
0.57%
C:
0.19%
JNJ
|
News
|
$144.77
0.22%
0.22%
7.9M
|
Health Technology
|
-8.33%
|
O:
-0.83%
H:
0.0%
C:
0.0%
ABBV
|
$164.25
1.05%
0.26%
3M
|
Health Technology
|
-7.17%
|
O:
0.01%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
-0.86%
|
O:
-0.6%
H:
0.0%
C:
0.0%
drug
patent
report
review
global
advanced
market
Global Biosimilar Monoclonal Antibodies Market Report 2024: Future Market Growth Powered by Biologics and Personalized Therapy Advances
Published:
2024-02-14
(Crawled : 20:00)
- prnewswire.com
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-4.06%
|
O:
1.95%
H:
0.0%
C:
0.0%
NVS
|
News
|
$93.08
-0.13%
0.13%
1.1M
|
Health Technology
|
-6.03%
|
O:
0.26%
H:
0.87%
C:
0.32%
ABBV
|
$164.25
1.05%
0.26%
3M
|
Health Technology
|
-5.35%
|
O:
0.48%
H:
1.56%
C:
1.48%
AMGN
|
$264.07
-0.59%
-0.59%
1.6M
|
Health Technology
|
-7.98%
|
O:
-0.75%
H:
0.86%
C:
0.41%
biosimilar
report
global
therapy
growth
market
Genmab Publishes 2023 Annual Report
Published:
2024-02-14
(Crawled : 16:00)
- globenewswire.com
GNMSF
|
$281.02
-1.44%
3.83%
210
|
Health Technology
|
7.15%
|
O:
2.65%
H:
4.56%
C:
1.23%
NVS
|
News
|
$93.08
-0.13%
0.13%
1.1M
|
Health Technology
|
-6.04%
|
O:
-0.02%
H:
0.24%
C:
0.01%
JNJ
|
News
|
$144.77
0.22%
0.22%
7.9M
|
Health Technology
|
-8.2%
|
O:
-0.91%
H:
0.0%
C:
0.0%
GMAB
|
$28.53
-3.06%
-3.23%
310K
|
Health Technology
|
7.95%
|
O:
1.32%
H:
5.34%
C:
3.02%
report
Global Epidural Abscess Treatment Market Report 2024 - Treatment Advances and Digital Health Technologies Shaping the Future of Epidural Abscess Care
Published:
2024-02-12
(Crawled : 15:30)
- prnewswire.com
AZNCF
|
$140.15
3.58%
-4.19%
560
|
Health Technology
|
9.56%
|
O:
-0.57%
H:
0.04%
C:
-1.74%
NVS
|
News
|
$93.08
-0.13%
0.13%
1.1M
|
Health Technology
|
-7.87%
|
O:
-1.46%
H:
1.04%
C:
0.97%
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
1.43%
|
O:
0.09%
H:
0.0%
C:
-0.48%
BMY
|
$47.84
-0.87%
0.48%
9.9M
|
Health Technology
|
-3.11%
|
O:
0.02%
H:
0.46%
C:
-0.14%
ABBV
|
$164.25
1.05%
0.26%
3M
|
Health Technology
|
-6.33%
|
O:
-0.83%
H:
0.7%
C:
-0.27%
ABT
|
News
|
$105.9
-3.03%
0.38%
11M
|
Health Technology
|
-3.85%
|
O:
-0.64%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
-1.05%
|
O:
-0.86%
H:
0.0%
C:
0.0%
AZN
|
$68.53
0.39%
0.39%
3.2M
|
Health Technology
|
9.65%
|
O:
-1.77%
H:
0.46%
C:
0.41%
AMGN
|
$264.07
-0.59%
-0.59%
1.6M
|
Health Technology
|
-8.31%
|
O:
-0.4%
H:
1.6%
C:
1.54%
report
health
treatment
care
global
market
Blood Cancer Drugs Market Report 2023: Reveals Striking Growth Prospects with a Surge in R&D Activities - Long-term Forecasts to 2028 and 2033
Published:
2024-02-06
(Crawled : 00:00)
- prnewswire.com
ALPMF
|
News
|
$9.594
1.2%
43.47%
0
|
Health Technology
|
-13.72%
|
O:
-1.53%
H:
0.0%
C:
0.0%
AZNCF
|
$140.15
3.58%
-4.19%
560
|
Health Technology
|
1.09%
|
O:
-0.37%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-8.98%
|
O:
0.41%
H:
0.0%
C:
0.0%
UCBJY
|
$64.07
1.2%
-4.38%
72K
|
Manufacturing
|
37.02%
|
O:
1.71%
H:
1.28%
C:
0.94%
ALPMY
|
News
|
$9.46
1.29%
-1.11%
500K
|
Manufacturing
|
-14.23%
|
O:
0.28%
H:
0.18%
C:
0.0%
TAK
|
$13.15
-0.61%
0.0%
1.5M
|
Health Technology
|
-7.13%
|
O:
0.07%
H:
0.42%
C:
0.07%
NVS
|
News
|
$93.08
-0.13%
0.13%
1.1M
|
Health Technology
|
-10.28%
|
O:
0.09%
H:
0.39%
C:
-0.36%
JNJ
|
News
|
$144.77
0.22%
0.22%
7.9M
|
Health Technology
|
-7.04%
|
O:
1.47%
H:
0.0%
C:
0.0%
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
6.49%
|
O:
0.76%
H:
4.31%
C:
2.11%
BMY
|
$47.84
-0.87%
0.48%
9.9M
|
Health Technology
|
-2.03%
|
O:
-0.14%
H:
0.35%
C:
-1.12%
ABBV
|
$164.25
1.05%
0.26%
3M
|
Health Technology
|
-4.15%
|
O:
1.48%
H:
0.0%
C:
0.0%
VRTX
|
$393.1
-0.27%
-0.27%
620K
|
Health Technology
|
-5.53%
|
O:
0.15%
H:
2.4%
C:
0.56%
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
-0.9%
|
O:
1.33%
H:
0.0%
C:
0.0%
JAZZ
|
News
|
$107.1
-1.65%
-1.63%
590K
|
Health Technology
|
-14.12%
|
O:
-0.02%
H:
0.0%
C:
-1.4%
AZN
|
$68.53
0.39%
0.39%
3.2M
|
Health Technology
|
1.83%
|
O:
-0.4%
H:
0.19%
C:
-0.33%
AMGN
|
$264.07
-0.59%
-0.59%
1.6M
|
Health Technology
|
-15.55%
|
O:
-0.18%
H:
0.0%
C:
-6.22%
report
cancer
blood
growth
market
← Previous
1
2
3
4
5
6
7
8
9
…
12
13
Next →
Gainers vs Losers
57%
43%
Top 10 Gainers
INVO
|
$1.82
139.47%
56.82%
220M
|
Health Technology
SINT
|
$0.0373
62.88%
37.26%
460M
|
Health Technology
WISA
4
|
$9.25
51.64%
34.27%
64M
|
Electronic Technology
EDBL
|
News
|
$6.66
46.37%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
600K
|
Manufacturing
TCON
|
$2.29
33.92%
26.61%
1.8M
|
Health Technology
TIRX
|
$0.4848
7.49%
24.58%
5.9M
|
SRFM
4
|
$0.3859
-12.3%
23.84%
660K
|
n/a
KZIA
|
$0.3442
18.28%
23.42%
290K
|
Health Technology
VNDA
|
News
|
$5.24
29.38%
22.56%
24M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.